Skip to main content
Figure 2 | Breast Cancer Research

Figure 2

From: Insulin-like growth factor-I inhibition with pasireotide decreases cell proliferation and increases apoptosis in pre-malignant lesions of the breast: a phase 1 proof of principle trial

Figure 2

Effect of treatment with pasireotide on cell proliferation and apoptosis in pre-malignant lesions of the breast. Effects of pasireotide on proliferation rate as assessed by immunohistochemistry for Ki67 in 12 proliferative (A) and 6 atypical hyperplasia (B) Apoptosis, as assessed by terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL), in 11 proliferative (C) and 6 atypical hyperplasia (D) lesions of the breast before and after 10 days of treatment with pasireotide.

Back to article page
\